Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Alexopoulos

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Autoimmunity|August 20, 2015
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4Eleni I Kampylafka, Harry Alexopoulos, Avraam El Hamidieh, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 26, 2020
Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patientsHarry Alexopoulos, Eleni Magira, Kleopatra Bitzogli, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Immunogenetic Studies in Patients With GAD-Positive Stiff-Person Syndrome Reveal Novel Lymphocytic Genes and <i>KLK10</i>-Gene VariantsPopianna Tsiortou, Harry Alexopoulos, Konstantinos Kyriakidis, et al.
Plos One|September 24, 2013
Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal lossThashi Chang, Harry Alexopoulos, Philippa Pettingill, et al.
Journal of the Neurological Sciences|June 22, 2014
Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylaseIoannis Markakis, Harry Alexopoulos, Cornelia Poulopoulou, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 14, 2016
Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar diseasePenelope Fouka, Harry Alexopoulos, Ioanna Chatzi, et al.
Trends in Molecular Medicine|May 10, 2022
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesisIoannis P Trougakos, Evangelos Terpos, Harry Alexopoulos, et al.
Trends in Molecular Medicine|September 16, 2022
COVID-19 mRNA vaccine-induced adverse effects: unwinding the unknownsIoannis P Trougakos, Evangelos Terpos, Harry Alexopoulos, et al.
Proteomics. Clinical Applications|March 14, 2026
Proteomic Analysis of Cerebrospinal Fluid from Severe COVID-19 Patients Reveals Prognostic Biomarkers Associated with Disease OutcomeHarry Alexopoulos, Martina Samiotaki, Eirini Gkogkou, et al.
Hemasphere|July 11, 2022
Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy IndividualsIoannis Ntanasis-Stathopoulos, Vangelis Karalis, Aimilia D Sklirou, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Autoimmunity|August 20, 2015
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4Eleni I Kampylafka, Harry Alexopoulos, Avraam El Hamidieh, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 26, 2020
Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patientsHarry Alexopoulos, Eleni Magira, Kleopatra Bitzogli, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Immunogenetic Studies in Patients With GAD-Positive Stiff-Person Syndrome Reveal Novel Lymphocytic Genes and <i>KLK10</i>-Gene VariantsPopianna Tsiortou, Harry Alexopoulos, Konstantinos Kyriakidis, et al.
Plos One|September 24, 2013
Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal lossThashi Chang, Harry Alexopoulos, Philippa Pettingill, et al.
Journal of the Neurological Sciences|June 22, 2014
Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylaseIoannis Markakis, Harry Alexopoulos, Cornelia Poulopoulou, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 14, 2016
Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar diseasePenelope Fouka, Harry Alexopoulos, Ioanna Chatzi, et al.
Trends in Molecular Medicine|May 10, 2022
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesisIoannis P Trougakos, Evangelos Terpos, Harry Alexopoulos, et al.
Trends in Molecular Medicine|September 16, 2022
COVID-19 mRNA vaccine-induced adverse effects: unwinding the unknownsIoannis P Trougakos, Evangelos Terpos, Harry Alexopoulos, et al.
Proteomics. Clinical Applications|March 14, 2026
Proteomic Analysis of Cerebrospinal Fluid from Severe COVID-19 Patients Reveals Prognostic Biomarkers Associated with Disease OutcomeHarry Alexopoulos, Martina Samiotaki, Eirini Gkogkou, et al.
Hemasphere|July 11, 2022
Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy IndividualsIoannis Ntanasis-Stathopoulos, Vangelis Karalis, Aimilia D Sklirou, et al.
Pageof 4